A Cheaper Diabetes Generic Arrives, yet Some Patients Risk Paying €40 for a €5 Pill
A generic version of the diabetes drug dapagliflozin has entered Portugal's reference-pricing system, but the APDP warns that if pharmacies run out of the generic, patients buying the branded original could pay around €40 for a medicine that recently cost €4 to €5.